GI disorder drugs Flashcards
Histamine-2 receptor antagonists prototype and other drug names
cimetidine (Tagamet)
Other: famotidine (pepcid)
histamine-2 receptor antagonist EPA
decreases amount, acidity and pepsin content of gastric juices by inhibiting histamine 2 receptors
histamine-2 receptor antagonist administration
PO, IV, IM
histamine-2 receptor antagonist therapeutic use
treats PUD, GERD, GI bleeding and Zollinger-Ellison syndrome
histamine-2 receptor antagonist ADRs
impotence, gynecomastia, decreased libido, confusion, arrhythmias, agranulocytosis, aplastic anemia
histamine-2 receptor antagonist contraindications and interactions
Can increase blood levels of warfarin, phenytoin, lidocaine, ketoconazole, and theophylline
Avoid NSAIDs, aspirin, alcohol or other GI irritants
histamine-2 receptor antagonist RN intervention and client education
Monitor for delirium
Education related to what medications to avoid
Admin IV slowly to prevent bradycardia
Avoid antacids with 1hr of admin
Proton pump inhibitors (PPI) prototype and other drug names
omeprazole (Prilosec)
Other drugs: pantoprazole (protonix), lansoprazole (Prevacid), esomeprazole (nexium)
PPI EPA
inhibitrs hydrogen potassium ATPase in the stomach thereby inhibiting gastric acid production
PPI administration
PO (immediate or ER) and IV
PPI therapeutic use
treats PUD and GERD with esophageal erosion and Zollinger-Ellison syndrome. GERD prophylaxis in the hospital setting 2/2 intubation or decreased mobility
PPI ADRs
risk for bone density loss with long term use; abdominal pain, nausea, vomiting, diarrhea; hypomagnesemia
PPI contraindications and interactions
Caution in pregnancy and lactation
Avoid ketoconazole
Increased warfarin, phenytoin, diazepam levels
St Johns wort decreases omeprazole levels
PPI RN intervention and client education
Should only take for 8 weeks at a time
Risk for osteoporosis increases with length of therapy
- Result of dec absorption of calcium 2/2 dec gastric acid
Take adequate amount of calcium, vit D, magnesium
Monitor for rebound acid hypersecretion when stopping medication
Maintain lowest dose possible for shortest amount of time
Report any diarrhea immediately (risk for cdiff)
mucosal protectant prototype
sucralfate (Carafate)
mucosal protectant EPA
causes chemical reaction in the stomach thereby creating a gel that coats ulcers and creates barrier between stomach and gastric secretions
mucosal protectant admin
orally on empty stomach; four times a day (QID); 1 hour before mealtime and at bettime (hs). Do not give within 30 minutes of antacids
mucosal protectant use
treats peptic ulcers 4-8 week treatment, may bind to ulcer and form a protective barrier from gastric acid
mucosal protectant ADRs
low incidence, not absorbed systemically, constipation and dry mouth
mucosal protectant contraindications and interactions
Decreased absorption of antibiotics: ciprofloxacin, tertracycline, and fluoroquinolones
Decreased absorption of digoxin, phenytoin, diazepam, and warfarin
mucosal protectant RN intervention and client education
Admin 2 hours before or after drugs above
Increase fluids and fiber intake
Report severe constipation or diarrhea
antacids prototype and other drug names
aluminum hydroxide (Amphojel)
Other drugs: magnesium hydroxide (Milk of Magnesia); calcium-carbonate (Tums)
antacids EPA
alkaline compounds that neutralize gastric acid
antacids administration
PO up to QID; take with full glass of water